News Daily News Chemo-Induced Vascular Dysfunction More Likely When Breast Cancer Occurs After Menopause Yael L. Maxwell January 23, 2026
News Daily News Weight Regained Within 18 Months of Stopping GLP-1 Drugs Michael O'Riordan January 08, 2026
News Daily News Reversal of Childhood Overweight May Prevent Later CHD Risks Todd Neale December 03, 2025
News Opinion Editor's Corner AHA 2025 What’s Going to Be Hot at AHA 2025? Michael O'Riordan November 05, 2025
News Daily News CV Death Rates in Autoimmune Disorders Waning, but Still Higher in Women L.A. McKeown May 14, 2025
News Conference News European Congress on Obesity 2025 App-Based Support Aids Weight Loss With Semaglutide, Studies Show Michael O'Riordan May 13, 2025
News Conference News European Congress on Obesity 2025 Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5 Michael O'Riordan May 12, 2025
News Daily News Lingering Gaps in CVD Care for Women Spotlighted in British Consensus Statement Todd Neale September 26, 2024
News Daily News Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea Michael O'Riordan June 21, 2024
News Daily News Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk Todd Neale December 12, 2023
News Daily News FDA Grants Tirzepatide a New Indication for Obesity Management L.A. McKeown November 08, 2023
News Features Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar L.A. McKeown May 12, 2023
News Daily News Cardiac Biomarkers Reflect Sex Hormones in Transgender People Caitlin E. Cox October 06, 2022
News Daily News SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients L.A. McKeown June 09, 2022
News Daily News Reassuring Data—and Some Lessons—From Pregnancy-Related SCAD Registry Caitlin E. Cox June 08, 2022
News Conference News EuroPCR 2022 Fibromuscular Dysplasia in SCAD Tied to Worse Long-term Prognosis Caitlin E. Cox May 19, 2022
News Daily News Women Less Likely Than Men to Experience SCD During Sports Michael O'Riordan December 21, 2021